PFIZER CEO: RECORDED FAVORABLE ADJUSTMENT TO REVENUES OF $771 MILLION FOR PAXLOVID, WHICH CONTRIBUTED 11 CENTS TO EPS IN Q1
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.28 USD | +2.50% | +1.29% | +1.39% |
04:44pm | Pfizer: RSV vaccine launched in Canada | CF |
05-21 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.39% | 162B | |
+36.83% | 723B | |
+32.22% | 598B | |
-2.28% | 364B | |
+20.22% | 331B | |
+3.54% | 288B | |
+16.36% | 244B | |
+9.87% | 210B | |
-5.40% | 208B | |
+8.86% | 169B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer Ceo: Recorded Favorable Adjustment To Revenues Of $771 M…